Abstract
Casoxins are food exorphins released from the κ-casein of milk protein. The genetic variants of κ-casein are AA, AB, BB, AC, BC, and AE. AA, AB, and BC κ-casein variants show casein micelle with diameters less than 200 nm and remaining variants form greater than 200 nm. Many reports establish BB fraction with increased and stronger gelling properties and better suitability for the preparation of cheeses. Casoxin A (YPSYGLN), B (YPYY), C (YIPIQYVLSR), and D (YVPFPPF) are protein fragments from 35–41, 57–60, 25–34, and 158–164, respectively, of κ-casein milk protein. Casoxins act as an opioid antagonist for the opioid receptors. Casoxin A has selectivity for all the three opioid receptors (μ/δ/κ). Casoxin D has selectivity for either μ or δ-opioid receptors. Casoxin B and C have an affinity for the only μ-opioid receptor. Casoxins have been reported to reverse the inhibitory action in the contractions induced by morphine in guinea pigs and mice in vitro. These exorphins have potential immunomodulatory roles in newborns that may be of the clinical significance in allergic diseases. It is suggested that these exorphins may have tremendous scope in the food and pharmacological industry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amenu B, Deeth H (2007) The impact of milk composition on Cheddar cheese manufacture. Aust J Dairy Technol 62:171–184
Amenu B, Cowan T, Deeth H et al (2006) Impacts of feeding system and season on milk composition and Cheddar cheese yield in a subtropical environment. Anim Prod Sci 46:299–306
Auldist M, Mullins C, O’Brien B et al (2002) Effect of cow breed on milk coagulation properties. Milchwissenschaft 57:140–143
Bijl E, De Vries R, Van Valenberg H et al (2014) Factors influencing casein micelle size in milk of individual cows: genetic variants and glycosylation of k-casein. Int Dairy J 34:135–141
Chiba H, Tani F, Yoshikawa M (1989) Opioid antagonist peptides derived from κ-casein. J Dairy Res 56:363–366
Dorian B (2009) Use of a peptide as a therapeutic agent. PCT/EP2008/007842
Fiedorowicz E, Jarmołowska B, Iwan M et al (2011) The influence of μ-opioid receptor agonist and antagonist peptides on peripheral blood mononuclear cells (PBMCs). Peptides 32(4):707–712
Ikonen T, Ahlfors K, Kempe R et al (1999) Genetic parameters for the milk coagulation properties and prevalence of noncoagulating milk in Finnish dairy cows. J Dairy Sci 82:205–214
Janecka A, Fichna J, Janecki T (2004) Opioid receptors and their ligands. Curr Top Med Chem 4:1–17
Johnsen LB, Rasmussen LK, Petersen TE et al (1994) Characterization of three types of human alpha s1-casein mRNA transcripts. Biochem J 309:237–242
Jõudu I, Henno M, Värv S et al (2009) The effect of milk proteins on milk coagulation properties in Estonian dairy breeds. Vet Zootec 46:14–19
Kato M, Fujiwara Y, Okamoto A et al (1995) Efficient production of casoxin D, a bradykinin agonist peptide derived from human casein, by bacillus brevis. Biosci Biotechnol Biochem 59(11):2056–2059
Lodes A, Krause I, Buchberger J et al (1996) The influence of genetic variants of milk proteins on the compositional and technological properties of milk. Casein micelle size and the content of non-glycosylated kappa-casein. Milchwissenschaft 51:368–373
Ng-Kwai-Hang K (1998) Genetic polymorphism of milk proteins: relationships with production traits, milk composition and technological properties. Can J Anim Sci 78:131–147
Patten GS, Head RJ, Abeywardena MY (2011) Effects of casoxin 4 on morphine inhibition of small animal intestinal contractility and gut transit in the mouse. Clin Exp Gastroenterol 4:23–31
Pihlanto-Leppala A (2000) Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends Food Sci Technol 11(9):347–356
Robitaille G, Ng-Kwai-Hang KF, Monardes HG (1993) Effect of k-casein glycosylation on cheese yielding capacity and coagulating properties of milk. Food Res Int 26:365–369
Takahashi M, Moriguchi S, Suganuma H et al (1997) Identification of casoxin c, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for c3a receptors. Peptides 18(3):329–336
Teschemacher H, Koch G, Brantl V (1997) Milk protein-derived opioid receptor ligands. Pept Sci 43(2):99–117
Walsh EM, McSweeney PLH, Fox PF (1996) Use of antibiotics to inhibit non-starter lactic acid bacteria in Cheddar cheese. Int Dairy J 6:425–431
Yoshikawa M, Tani F, Ashikaga T et al (1986) Purification and characterization of an opioid antagonist from a peptide digest of bovine κ-casein. Agric Biol Chem 50:2951–2954
Yoshikawa M, Tani F, Shiota H et al (1994) Casoxin D, an opioid antagonist ileum-contracting/vasorelaxing peptide derived from human αs1-casein. In: Brantl V, Teschemacher H (eds) β-casomorphins and related peptides: recent developments. Wiley, Weinheim, pp 43–48
Yoshikawa M, Takahashi M, Yang S (2003) Delta opioid peptides derived from plant proteins. Curr Pharm Des 9(16):1325–1330
Zioudrou C, Streaty RA, Klee WA (1979) Opioid peptides derived from food proteins. J Biol Chem 254(7):2446–2449
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ul Haq, M.R. (2020). Casoxins. In: Opioid Food Peptides. Springer, Singapore. https://doi.org/10.1007/978-981-15-6102-3_5
Download citation
DOI: https://doi.org/10.1007/978-981-15-6102-3_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-6101-6
Online ISBN: 978-981-15-6102-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)